UAE Strengthens Pharmaceutical Stockpile, Ensures Security and Sufficiency
The United Arab Emirates is reinforcing its pharmaceutical sector to ensure ongoing stability and preparedness, as stated by Saeed bin Mubarak Al Hajeri, the Minister of State and Chairman of the Board of Directors of the Emirates Drug Establishment. The minister confirmed that the nation’s strategic stockpile of medicines and medical supplies is secure and adequately meets the demands of its local market.
Al Hajeri emphasized that the UAE has implemented best-in-class policies to maintain a strategic reserve that guarantees the availability of essential medicines for citizens, residents, and visitors. This ensures that required quantities are maintained over extended periods.
National Priority
The minister classified the enhancement of pharmaceutical security as a national priority, bolstered by a comprehensive strategic vision aimed at consistently ensuring the quality and safety of medicines. This vision seeks to protect the availability of essential healthcare products under all circumstances.
In reinforcing this resolve, Al Hajeri indicated that the Emirates Drug Establishment adopts a proactive approach based on risk assessment and emergency planning. Such measures are designed to enhance public confidence in the nation’s pharmaceutical infrastructure.
Sector Readiness
Dr. Fatima Al Kaabi, Director-General of the Emirates Drug Establishment, underscored the operational readiness and stability of the pharmacy sector, ensuring the reliable provision of medicines and medical supplies that adhere to the highest safety and quality standards.
Dr. Al Kaabi highlighted that daily field monitoring is conducted, overseeing the movement and stock levels of medicines at factories, warehouses, and storage facilities. This oversight is facilitated through integrated systems in collaboration with strategic partners.
Such efforts ensure that essential medicines remain readily available and that shortages of key products are prevented. The overall pharmaceutical supply chains within the UAE are functioning effectively and as intended.
Availability Indicators
The Director-General remarked that current indicators for the availability of medical products are stable and reassuring. This positive status stems from effective forward planning and robust partnerships among various stakeholders, including the Ministry of Health and Prevention, relevant authorities, and the private sector.
Dr. Al Kaabi further noted that maintaining pharmaceutical security is a fundamental pillar of healthcare in the UAE. The Emirates Drug Establishment is committed to employing a forward-looking strategy aimed at ensuring sustainable medicine supplies while preparing the health sector to effectively address a range of scenarios.
For further information on healthcare initiatives in the UAE, please refer to a related article on healthcare strategies in the region.
Published on 2026-03-04 12:53:00 • By Editorial Desk • Category: UAE,/22312099265/Emirates247/UAE
